Tiger Newspress01-09 21:12
Insmed reported preliminary 2025 revenue Friday of $606.4 million, up 67% year over year. Analysts polled by FactSet expect $518 million.
US revenue for the year grew 78% to $453 million, while international sales jumped 41% to $153.5 million, according to Insmed. The company said it will report final Q4 and 2025 financial results in February. Insmed shares were up 10% in recent premarket activity.
Crypto shares jumped in premarket trading. DeFi Tech up over 4%; IREN up 3%; TeraWulf up 2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
